臺大學術典藏 |
2022-08-19T00:21:15Z |
Recent advances in non-surgical treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Cheng J.C.-H.; Cheng A.-L. |
臺大學術典藏 |
2022-08-19T00:21:15Z |
Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13
|
Chie W.-C.; Yang C.-H.; CHIUN HSU; Yang P.-C. |
臺大學術典藏 |
2022-08-19T00:21:15Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.; Wu C.-Y.; Chen J.-S.; Li C.-C.; Liu H.-T.; Hsu C.-H.; Lu Y.-S.; Yeh K.-H.; Yang C.-H.; Shen Y.-C.; CHIUN HSU |
臺大學術典藏 |
2022-08-19T00:21:16Z |
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia
|
Tang J.-L.; Chen Y.-C.; Cheng A.-L.; Chang S.-M.; Tien H.-F.; Hwang J.-S.; Wang J.-D.; CHIUN HSU |
臺大學術典藏 |
2022-08-19T00:21:16Z |
Using standardised measures of health-related quality of life: Critical issues for users and developers
|
Kind P.; CHIUN HSU; Wang J.-D.; Yao G.; Tang J.-L. |
臺大學術典藏 |
2022-08-19T00:21:16Z |
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-na?ve patients with locally advanced or metastatic breast carcinoma
|
Cheng A.-L.; Chang K.-J.; Chen M.M.; Lu Y.-S.; Bu C.-F.; CHIUN HSU; Huang C.-S.; Chao T.-Y. |
臺大學術典藏 |
2022-08-19T00:21:16Z |
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
|
CHIUN HSU; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; Lee P.-H.; Cheng A.-L. |
臺大學術典藏 |
2022-08-19T00:21:17Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Yeh K.-H.; Bu C.-F.; Lin C.-C.; Lu Y.-S.; Yang C.-H.; CHIUN HSU; Cheng A.-L.; Hsu C.-H. |
臺大學術典藏 |
2022-08-19T00:21:17Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Cheng A.-L.; Wang S.-J.; Lee P.-H.; Huang C.-L.; Hsu H.-C.; CHIUN HSU |
臺大學術典藏 |
2022-08-19T06:25:27Z |
Feminist Cyborg Writing and the Imagining of Asia
|
HUI-CHUAN CHANG |
臺大學術典藏 |
2022-08-19T06:28:42Z |
Perspectives on Utopia: Generic Investigation and Textual Exploration
|
張惠娟 |
臺大學術典藏 |
2022-08-19T06:31:05Z |
Perspectives on the New Millennium: Le Guin's Changing Planes
|
HUI-CHUAN CHANG |
臺大學術典藏 |
2022-08-19T06:32:03Z |
Feminist Cyborg Writing and the Imagining of Asia
|
HUI-CHUAN CHANG |
臺大學術典藏 |
2022-08-19T06:48:40Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
Shao Y.-Y.; Kuo H.-Y.; Jeng Y.-M.; Wu Y.-M.; Wang H.-P.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z. |
臺大學術典藏 |
2022-08-19T06:48:41Z |
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)
|
Kitagawa Y.; Matsumura Y.; Takazawa A.; Hamamoto Y.; Doki Y.; Yen C.-C.; Kubota Y.; Kim S.-B.; CHIH-HUNG HSU; Holtved E.; Xynos I.; Ahn M.-J.; Kadowaki S.; Cho B.C.; Takahashi M.; Lin C.-Y.; Chin K.; Okada M.; Kato K. |
臺大學術典藏 |
2022-08-19T06:48:42Z |
AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review
|
Hsu C.; Huang Y.-H.; Lin S.-M.; CHIH-HUNG HSU |
臺大學術典藏 |
2022-08-19T06:48:43Z |
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
|
Wang Y.; Burgoyne A.M.; Dayyani F.; Spahn J.; Verret W.; Finn R.S.; Toh H.C.; Lujambio A.; Yau T.; Kaseb A.O.; Ryoo B.-Y.; He A.R.; CHIH-HUNG HSU; Zhang W.; Koeppen H.; Lu S.; Guan Y.; de Galarreta M.R.; Abbas A.R.; Zhu A.X. |
臺大學術典藏 |
2022-08-19T06:48:44Z |
Impact of expanded strong opioid availability on opioid prescription patterns in patients with cancer: A population-wide cohort study in Taiwan
|
Wu T.-C.; CHIH-HUNG HSU; Sun W.-Z.; Chen H.-M.; Lin C.-P.; Shao Y.-Y. |
臺大學術典藏 |
2022-08-19T06:48:44Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU |
臺大學術典藏 |
2022-08-19T06:48:44Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Hsu C.-H.; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N.; Chao Y.; Chen J.-S.; Bang Y.-J.; Bendell J.; Lee K.-H.; Wang Y.; Abdullah H.; Liu B.; Spahn J.; Hack S.P.; Verret W.; CHIH-HUNG HSU; Lee M.S. |
臺大學術典藏 |
2022-08-19T07:01:53Z |
Opacity
|
CHI-SHE LI |
臺大學術典藏 |
2022-08-19T07:05:53Z |
Multiple Modernities and the Imaging of Uselessness in Contemporary Chinese Cinema
|
CHI-SHE LI; Michelle Huang Tsung-yi |
臺大學術典藏 |
2022-08-19T07:10:55Z |
“Like a Family, But Not Quite”: Emotional Labor and Cinematic Politics of Intimacy
|
Tsung-yi Michelle Huang; CHI-SHE LI |
臺大學術典藏 |
2022-08-19T07:33:44Z |
On a Knowledge Which Does Not Cease Not to be Written
|
CHIH-CHUNG SHEN |
臺大學術典藏 |
2022-08-19T07:34:50Z |
何者聽:聲響迴盪
|
沈志中 |